Compare FURY & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FURY | ALPS |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Canada | Malaysia |
| Employees | N/A | N/A |
| Industry | Precious Metals | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2M | 126.4M |
| IPO Year | 2011 | N/A |
| Metric | FURY | ALPS |
|---|---|---|
| Price | $0.53 | $0.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.70 | N/A |
| AVG Volume (30 Days) | ★ 290.4K | 20.8K |
| Earning Date | 08-11-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.56 |
| 52 Week High | $1.02 | $1.72 |
| Indicator | FURY | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 36.78 |
| Support Level | $0.51 | $0.65 |
| Resistance Level | $0.63 | $1.11 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 33.33 | 2.94 |
Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.